Author

I. Berezniuk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Y. Park· 2 shared A. W. Stranahan· 1 shared B. Kroger· 1 shared E. G. Kapti· 1 shared F. Feller· 1 shared J. Dempsey· 1 shared K. Mims· 1 shared L. Guo· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Y. Park

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD99 Promotes Self-renewal in Hematopoietic Stem Cells and Leukemia Stem Cells by Regulating Protein Synthesis

Y. Huang, E. G. Kapti, Y. Ji, T. Thomas, J. Dempsey, K. Mims, I. Berezniuk, L. Guo, B. Kroger, W. Hu, C. Y. Park, S. S. Chung

This study shows CD99 regulates protein synthesis in hematopoietic stem cells and leukemia stem cells, promoting self-renewal and clonal expansion leading to AML.

bioRxiv · Feb 21, 2023Cancer Biology

Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemia

C. Y. Park, A. W. Stranahan, I. Berezniuk, S. Chakraborty, F. Feller, M. Khalaj

This study identifies ALOX5 as a mediator of chemoresistance in AML by promoting LSC self-renewal through LTB4-BLTR signaling, suggesting ALOX5 inhibition could enhance chemotherapy efficacy.

bioRxiv · Feb 7, 2022 · PreprintCancer Biology